Japanese study tracks Esperoct's Real-World safety over two years
NCT ID NCT04334057
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watched 23 people with hemophilia A who were already using Esperoct as part of their normal care. Researchers tracked side effects and how well the medicine worked over about two years. The goal was to confirm the drug's safety and effectiveness in everyday use, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gifu University Hospital
Gifu, 501-1194, Japan
-
Gifu University Hospital_The Third Dept. of Internal Medicine
Gifu, 501-1194, Japan
-
Kurume University Hospital, Pediatrics
Fukuoka, 830-0011, Japan
-
Lake Children Clinic
Shiga, 520-2145, Japan
-
Nanbu Medical Center & Children's Medical Center_Pediatric Hematology
Okinawa, 901-1193, Japan
-
Nara Medical University Hospital_Pediatrics
Nara, 634-8522, Japan
-
Nihonkai Sogo Hospital
Yamagata, 998-8501, Japan
-
Nihonkai Sogo Hospital_Internal Medicine
Yamagata, 998-8501, Japan
-
Nippon Medical School Hospital_Haematology
Tokyo, 113-8603, Japan
-
Ogikubo Hospital_Blood Coagulation
Tokyo, 167-0035, Japan
-
Saitama Medical University Hospital, Pediatrics
Iruma-gun, Saitama, 350 0495, Japan
-
Shibuya Children's Clinic, Department of Pediatric
Saitama, 350-0225, Japan
-
Shizuoka Children's Hospital
Shizuoka, 420-8660, Japan
-
Shizuoka Children's Hospital, Hematology-Oncology
Shizuoka, 420-8660, Japan
-
St. Marianna Univ., Yokohama City Seibu HP, Pediatrics Dept,
Yokohama-shi, Kanagawa, 241-0811, Japan
-
St. Marianna University School of Medicine Hospital
Kanagawa, 216-8511, Japan
-
St. Marianna University School of Medicine Hospital_Pediatrics
Kanagawa, 216-8511, Japan
-
Tokyo Medical Univ. Hospital
Tokyo, 160-0023, Japan
-
Tokyo Medical Univ. Hospital_Laboratory Medicine
Tokyo, 160-0023, Japan
-
University Hospital Kyoto Prefectual University of Medicine
Kamigyo-ku, Kyoto, 602-8566, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an ultra-long-acting factor VIII simplify surgery for hemophilia a patients?
- Patient voices take center stage in haemophilia a treatment decisions
- Japanese hemophilia patients monitored on alhemo in new safety study
- New hope for haemophilia a patients: immune tolerance induction may eliminate clotting factor blockers
- New hope for kids with hemophilia: can SCT800 stop bleeds before they start?
- New shot Mim8 shows promise for hemophilia a bleed control